Browse verified doctors or let our care team help you find the doctor best suited to your condition, treatment goals, and budget.
At Prince Court Medical Centre, Immunotherapy is delivered through individualized oncology treatment plans and modern diagnostic and therapeutic facilities. Established in 2007, the MSQH accredited hospital in Kuala Lumpur, Malaysia has 277 beds and provides comprehensive cancer care.
Immunotherapy is a form of cancer treatment designed to stimulate or enhance the immune system's ability to fight malignant cells. It may be used alone or combined with treatments such as chemotherapy, radiation therapy, targeted therapy, or surgery, depending on the patient's diagnosis. Treatment is selected according to factors such as cancer type, stage, molecular characteristics, and previous therapies. Regular clinical assessments and laboratory tests help monitor response and safety.
Parkway Pantai provides dedicated Immunotherapy services with an emphasis on evidence-based cancer treatment, individualized therapy selection, and ongoing safety assessment. Established in 1974, the JCI, MSQH accredited hospital is based in Kuala Lumpur, Malaysia and has 499 beds supported by modern medical oncology facilities.
Immunotherapy can be used to support the body's natural immune response against certain cancers. Before starting therapy, specialists may review pathology reports, imaging results, biomarkers, previous treatments, and the patient's general health. Depending on the clinical situation, immunotherapy may be administered intravenously or through other approved routes and may be given for a defined number of cycles or until disease progression or unacceptable toxicity occurs. Follow-up assessments help determine treatment response and manage potential side effects.
Sunway Medical Centre provides specialized Immunotherapy with a focus on personalized cancer care, appropriate treatment selection, and close monitoring during therapy. Established in 1999, the ACHS accredited hospital is located in Kuala Lumpur, Malaysia and operates 724 beds with advanced oncology and infusion-care facilities.
Immunotherapy uses medicines that help the body's immune system recognize and attack cancer cells more effectively. Depending on the cancer type and its characteristics, treatment may include immune checkpoint inhibitors, monoclonal antibodies, or other immune-based therapies. Before treatment, doctors may evaluate the cancer type, stage, biomarkers, and overall health to determine whether immunotherapy is appropriate. Patients are monitored regularly for treatment response and possible immune-related side effects.
ParkCity Medical Centre provides dedicated Immunotherapy services with an emphasis on evidence-based cancer treatment, individualized therapy selection, and ongoing safety assessment. Established in 2012, the JCI accredited hospital is based in Kuala Lumpur, Malaysia and has 300 beds supported by modern medical oncology facilities.
Immunotherapy can be used to support the body's natural immune response against certain cancers. Before starting therapy, specialists may review pathology reports, imaging results, biomarkers, previous treatments, and the patient's general health. Depending on the clinical situation, immunotherapy may be administered intravenously or through other approved routes and may be given for a defined number of cycles or until disease progression or unacceptable toxicity occurs. Follow-up assessments help determine treatment response and manage potential side effects.
At Subang Jaya Medical Centre, Immunotherapy is delivered through individualized oncology treatment plans and modern diagnostic and therapeutic facilities. Established in 1985, the JCI accredited hospital in Kuala Lumpur, Malaysia has 442 beds and provides comprehensive cancer care.
Immunotherapy is a form of cancer treatment designed to stimulate or enhance the immune system's ability to fight malignant cells. It may be used alone or combined with treatments such as chemotherapy, radiation therapy, targeted therapy, or surgery, depending on the patient's diagnosis. Treatment is selected according to factors such as cancer type, stage, molecular characteristics, and previous therapies. Regular clinical assessments and laboratory tests help monitor response and safety.
Bukit Tinggi Medical Centre provides specialized Immunotherapy with a focus on personalized cancer care, appropriate treatment selection, and close monitoring during therapy. Established in 2016, the MSQH accredited hospital is located in Kuala Lumpur, Malaysia and operates 171 beds with advanced oncology and infusion-care facilities.
Immunotherapy uses medicines that help the body's immune system recognize and attack cancer cells more effectively. Depending on the cancer type and its characteristics, treatment may include immune checkpoint inhibitors, monoclonal antibodies, or other immune-based therapies. Before treatment, doctors may evaluate the cancer type, stage, biomarkers, and overall health to determine whether immunotherapy is appropriate. Patients are monitored regularly for treatment response and possible immune-related side effects.
We at MediGence are honoured to have been part of Krispin's journey. His resilience reminds us that healthcare is not just about medicine, but also…
| Speciality | Oncology |
| Procedure | Immunotherapy |
| Success Rate | Varies as per stage, grade and type of cancer |
| Recovery Time | Few weeks to several months |
| Treatment Time | Up to 2 Years in some cases |
| Chances of Recurrence | Varies as per stage, grade, type and location of cancer |
It's a fact that while ranking a hospital, certain factors need to be considered. While categorizing hospitals for Immunotherapy in Malaysia, some of the important factors are Popularity of the procedure, Infrastructure, Availability of the treatment, Skilled Medical Professionals, Technology employed, Cost, Facilities Offered, and Success Rate.
MediGence puts forth a lot of effort to make your medical travel of the finest quality, convenient, and affordable for you. While travelling for treatment abroad, MediGence makes sure that your healthcare journey should be smooth and hassle-free. These caregiving services are airport transfers, accommodation, 24/7 assistance, Online consultation, Assigned Patient Coordinator, and Prebundled treatment packages with upto a 30% discount. Many more benefits are available with MediGence your treatment abroad.
Yes, it's simple to do that. While talking to one of our experts, you can request a video consultation appointment. They will finalize your appointment after confirming the doctor's availability and sending the payment link.
Numerous people have started traveling to Malaysia for Immunotherapy because of the nation's state-of-the-art healthcare system and high success rate. Other factors that contribute to Malaysia being the best choice for Immunotherapy include:
The severity of the treatment and the patient's general health both influence how long recovery takes after treatment. In addition, post-treatment rehabilitation is extremely important for speeding up recovery and minimizing recovery time. To speed up recovery, it is advised that the patient maintain regular contact with their surgeon for a few months after surgery.